Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

Kamene Kimenye

Работ: 6

Programmatic Management of Drug-Resistant Tuberculosis, Nairobi, Kenya

  1. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    ДругоеTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine2015Цитирований: 1
    ABI

  2. Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)

    Maryline Bonnet, Mathieu Bastard, Philipp du Cros +7

    СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2013Цитирований: 0
    ABI

  3. A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients

    Cathy Hewison, Teshome Ashagre, Tigay Zinaida +7

    СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2013Цитирований: 0
    ABI

  4. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

    M. Bonnet, Mathieu Bastard, Philipp du Cros +9

    СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2015Цитирований: 0
    ABI

  5. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    ДругоеTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine2015Цитирований: 0
    ABI

  6. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

    Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

    СтатьяTuberculosis Research and EpidemiologyPLoS ONE2018Цитирований: 0
    ABI